Picture of Selectimmune Pharma AB logo

SELECT B Selectimmune Pharma AB Balance Sheet

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Selectimmune Pharma AB, fiscal year end - June 30th, SEK millions except per share, conversion factor applied.

2018
June 30th
2019
June 30th
2020
June 30th
2021
June 30th
2022
June 30th
Period Length:
Source:ARSARSARSARSARS
Standards:
SAS
SAS
SAS
SAS
SAS
Status:FinalFinalFinalFinalFinal
Cash
Cash and Short Term Investments0.04934.92326.611.2
Net Total Receivables01.40.1040.630.6
Prepaid Expenses
Total Current Assets0.04938.323.227.411.9
Net Property, Plant And Equipment1.921.521.12
Total Assets0.04938.325.128.913
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities0.0125.650.7123.021.22
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities0.0125.650.7123.021.22
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity0.03732.624.425.911.8
Total Liabilities & Shareholders' Equity0.04938.325.128.913
Total Common Shares Outstanding